Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Immuron Ltd (IMRN)

2.1616   0.192 (9.73%) 06-03 11:18
Open: 2.17 Pre. Close: 1.97
High: 2.17 Low: 2.02
Volume: 2,208 Market Cap: 10M
Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.233 - 2.247 2.247 - 2.256
Low: 1.891 - 1.906 1.906 - 1.917
Close: 1.949 - 1.972 1.972 - 1.989

Technical analysis

as of: 2020-06-03 12:59:22 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.88     One year: 3.35
Support: Support1: 1.81    Support2: 1.51
Resistance: Resistance1: 2.47    Resistance2: 2.87
Pivot: 2.01
Moving Average: MA(5): 2.13     MA(20): 2.04
MA(100): 2.67     MA(250): 3.01
MACD: MACD(12,26): -0.04     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 52.19     %D(3): 63.42
RSI: RSI(14): 51.22
52-week: High: 7.25  Low: 1.55  Change(%): -26.7
Average Vol(K): 3-Month: 2073  10-Days: 756

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
IMRN has closed below upper band by 22.5%. Bollinger Bands are 44.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to IMRN's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 28 Apr 2020
Immuron Board Relinquish Cash Payment of Fees - GlobeNewswire

Mon, 03 Feb 2020
Immuron's Technology Platform of Treatments in the Age of the Coronavirus Outbreak - GlobeNewswire

Mon, 20 Apr 2020
Immuron North American Travelan® Sales Up 95%, Global Sales Up 60% - GlobeNewswire

Mon, 04 Nov 2019
Immuron Receives AUD $0.53M R&D Tax Concession Refund - GlobeNewswire

Mon, 14 Oct 2019
Immuron North American Q1 Sales Up 111% YoY - GlobeNewswire

Tue, 16 Jul 2019
Immuron North American revenue surges by 52% in FY19 - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Shares Out. (M) 4
Shares Float (M) 3
% Held by Insiders
% Held by Institutions 2.97
Shares Short (K) 4
Shares Short P. Month (K) 3

Stock Financials

EPS -0.680
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.760
Profit Margin -153.11
Operating Margin
Return on Assets (ttm) -35.7
Return on Equity (ttm) -64.8
Qtrly Rev. Growth 59.1
Gross Profit (p.s.) 0.386
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -3.18
PEG Ratio
Price to Book value 1.23
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.